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Background: Microcell-mediated chromosome transfer (MMCT) was developed to introduce a low number of
chromosomes into a host cell. We have designed a novel technique combining part of MMCT with somatic cell
nuclear transfer, which consists of injecting a somatic micronucleus into an enucleated oocyte, and inducing its
cellular machinery to replicate such micronucleus. It would allow the isolation and manipulation of a single or a
low number of somatic chromosomes.
Methods: Micronuclei from adult bovine fibroblasts were produced by incubation in 0.05 μg/ml demecolcine for
46 h followed by 2 mg/ml mitomycin for 2 h. Cells were finally treated with 10 μg/ml cytochalasin B for 1 h. In vitro
matured bovine oocytes were mechanically enucleated and intracytoplasmatically injected with one somatic
micronucleus, which had been previously exposed [Micronucleus- injected (+)] or not [Micronucleus- injected (−)]
to a transgene (50 ng/μl pCX-EGFP) during 5 min. Enucleated oocytes [Enucleated (+)] and parthenogenetic
[Parthenogenetic (+)] controls were injected into the cytoplasm with less than 10 pl of PVP containing 50 ng/μl
pCX-EGFP. A non-injected parthenogenetic control [Parthenogenetic (−)] was also included. Two hours after
injection, oocytes and reconstituted embryos were activated by incubation in 5 μM ionomycin for 4 min + 1.9 mM
6-DMAP for 3 h. Cleavage stage and egfp expression were evaluated. DNA replication was confirmed by DAPI
staining. On day 2, Micronucleus- injected (−), Parthenogenetic (−) and in vitro fertilized (IVF) embryos were
karyotyped. Differences among treatments were determined by Fisher0s exact test (p≤0.05).
Results: All the experimental groups underwent the first cell divisions. Interestingly, a low number of
Micronucleus-injected embryos showed egfp expression. DAPI staining confirmed replication of micronuclei in most
of the evaluated embryos. Karyotype analysis revealed that all Micronucleus-injected embryos had fewer than 15
chromosomes per blastomere (from 1 to 13), while none of the IVF and Parthenogenetic controls showed less than
30 chromosomes per spread.
Conclusions: We have developed a new method to replicate somatic micronuclei, by using the replication
machinery of the oocyte. This could be a useful tool for making chromosome transfer, which could be previously
targeted for transgenesis.
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Manipulation of genetic information has been under in-
vestigation for many years. However, manipulation of
chromosomes has only been attempted by the gener-
ation and use of artificial chromosomes capable of carry-
ing large DNA sequences, e.g. YAC’s (yeast artificial
chromosomes) [1,2] and HAC’s (human artificial chro-
mosomes [3,4]. Although such molecules can carry large
fragments of DNA, the isolation and manipulation of in-
dividual entire chromosomes has never been achieved.
In 1974, Ege and Ringertz developed a methodology for
generating cells with small amounts of DNA [5]. These
cells, having only one or a few chromosomes (microcells)
were first fused with mitotic cells to generate hybrid
karyotypes by Schor et al. [6]. In 1977, Fournier and
Ruddle [7] designed the microcell-mediated chromosome
transfer technique (MMCT) which is still used to intro-
duce a low number of chromosomes into host somatic
cells [8,9]. This technique has been used in several ways,
mainly for the mapping of genes, like tumor suppressor
genes [10-15], telomerase suppressor genes [16-19], senes-
cence inducing genes [20-22], and genes involved in DNA
repair pathways [23-25]. It has also been used to study the
effect of genomic imbalances on chromosome- specific
gene expression patterns and the behavior of polysomies
in different cell lines [26,27], and for analysis of genomic
imprinting [28-30].
Recipient cell types used for MMCT can be somatic
cells, embryonic carcinoma (EC) or embryonic stem (ES)
cells, which are employed to study in vitro or in vivo
effects of the transferred chromosomes [31]. This
method consists of the chemical micronucleation of a
donor cell line whose chromosome under study contains
a dominant selectable marker. Treated cells develop sev-
eral micronuclei, which contain one or, at most, a few
chromosomes. Microcells are then isolated by high
speed centrifugation in the presence of cytochalasin B.
After a filtration process, microcells with the smallest
number of chromosomes are collected and finally fused
with recipient somatic cells. The dominant selectable
marker previously introduced into donor cells allows
recognition of resulting hybrid cell lines which have
incorporated the chromosome of interest [32,33]. In this
way, MMCT can be considered as a simple way to ma-
nipulate an entire chromosome as a structural unit.
Nevertheless, it is not possible to select and replicate
such chromosomes individually.
It is well known that the oocyte has the capacity to
replicate varied numbers of chromosomes. It has been
demonstrated that haploid, polyploid and mixoploid
embryos can cleave and also reach the blastocyst stage
in the bovine [34,35], porcine [36] and human [37-40].
Polyploid blastocysts have also been produced in rabbits
[41] and mice [42]. Additionally, it has been establishedthat the mammalian oocyte can replicate not only the
genetic information from the gametes [43,44], but also
from somatic cells [45,46], including cells from different
species [47]. Mouse first polar bodies have also been
used as nuclear donors [48]. After injection of polar
bodies, enucleated oocytes were subjected to ICSI and
fertile offspring were obtained following embryo transfer
to foster mothers [48]. In addition, bovine embryos
reconstituted with non enucleated oocytes showed simi-
lar cleavage and blastocyst rates to those reconstituted
with enucleated oocytes [49]. On the basis of these pre-
vious results, we can propose that the oocyte is capable
of replicating a wide range of numbers and types of
chromosomes.
The MMCT technique is still widely used, even
though the methodology has not undergone any major
technical changes since it was developed. In the present
work, we gave a new focus to this technique by using
the bovine ooplast to copy a single or low number of
chromosomes. With the aim of generating several copies
of individual chromosomes to be able to manipulate
them, we combined part of the MMCT technique with
somatic cell nuclear transfer (SCNT). The new method-
ology that we designed consists of injecting one somatic
micronucleus into an enucleated oocyte and inducing
the injected oocyte to cleave. Each blastomere from the
injected oocytes should have a copy of the donor micro-
nucleus, giving rise to the replication of an individual
chromosome or of a low number of chromosomes.
We also tested the ability of somatic micronuclei to
express a transgene after being injected into an ooplast.
Recently, we demonstrated a spontaneous and quick
interaction between DNA and donor cells or fragments
of ooplasm surrounded by oolema (vesicles) [50]. In this
study, cumulus cells previously exposed to pCX-EGFP
plasmid for 5 min were injected into enucleated bovine
oocytes and gave rise to egfp expressing embryos by
SCNT. Vesicles exposed to pCX-EGFP were injected
into MII oocytes and IVF embryos, resulting in the pro-
duction of parthenogenetic and IVF egfp expressing
embryos respectively. On the basis of these results, we
hypothesize that the membranes surrounding micronu-
clei are also capable of binding DNA, resulting in the
production of egfp expressing embryos.
In summary, after chemical activation, cleavage oc-
curred, and some micronuclei were replicated. A low
number of chromosomes (1–13) was detected. Addition-
ally, a small proportion of micronuclei- injected oocytes
showed transgene expression. The possibility of generat-
ing embryos containing only one chromosome would
allow us to genetically modify, identify and transfer indi-
vidual chromosomes, while multiplying them into many
blastomeres. In this way, it would be possible to confirm
which chromosome has been replicated by the oocyte
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blastomeres. This method constitutes a first approach to
individual chromosome manipulation.Results and discussion
Induction of somatic micronuclei
With the aim of inducing the formation of somatic
micronuclei, several chemical treatments were tested on
primary cell cultures. Although there are no previous
reports of the generation of micronuclei in bovine cells,
we assayed different treatments to induce a block in
metaphase, on the basis of human or mouse protocols
[7,10,26,51]. Somatic cells were treated with 0.05 or
0.1 μg/ml demecolcine (DMC); or 0.05 μg/ml colchicine
(Col) for 46 or 48 h, followed or not by incubation with
2 mg/ml mitomycin (Mit) for 2 h. The six treatments
assayed were named DMC 0.05 μg/ml; DMC 0.05 μg/ml +
Mit; DMC 0.1 μg/ml; DMC 0.1 μg/ml + Mit; Col
0.05 μg/ml; and Col 0.05 μg/ml + Mit. A total of 300 to
500 cells per treatment were evaluated. No differences
were found between groups in percentages of cells that
became micronucleated over total number of cells
(Table 1), except for DMC 0.05 μg/ml + Mit, which
showed a significantly higher value (21.75 vs. 3.25 to 10%)
(p≤0.05). All treatments induced similar numbers of
micronuclei per cell, varying from 2 to 20. Rates of micro-
nucleation were very low compared to mouse lines from
previous studies. This might be due to the cell type used
as donor, because not all cells are capable of micronucleat-
ing with the same efficiency (Eric Shoubridge, personal
communication). In mice, the cell line mostly used for
MMCT experiments is the A9 line, which has low tumori-
genicity and lacks hypoxanthine phosphoribosyltransfer-
ase and adenine phosphoribosyltransferase [52]. It has
been s reported to have rates of micronucleation of
80-90% after a 48 h treatment with colcemide [7]. Because
of its high efficiency, it has been widely employed for gen-
erating microcells [8,26,53]. On the basis of the low rates
of micronucleation obtained, we decided to treat cells with
mitomycin, to complete mitotic arrest, as described byTable 1 Evaluation of different combinations of spindle inhib
somatic micronuclei
Spindle inhibitor Mit % Micronuc
DMC 0.05 μg/ml -
+
DMC 0.1 μg/ml -
+
Col 0.05 μg/ml -
+
Ovarian bovine fibroblasts were blocked in metaphase by incubation with 0.05 or 0
order to complete mitotic arrest, some cells were then incubated with 2 mg/ml Mit
a,b: Values with different superscripts in the same column differ significantly (p≤0.05De Lonlay et al. [54] who synchronized transformed
rodent cell lines. DMC 0.05 μg/ml + Mit treatment
produced the best results, and was therefore chosen to
generate micronucleate cells for further experiments.Cleavage and egfp expression of enucleated and
micronucleus injected bovine oocytes
On the basis of experiment 1, DMC 0.05 μg/ml + Mit
treatment was employed to generate micronucleate cells.
Micronuclei previously incubated or not with pCX-
EGFP were injected into enucleated oocytes. Cleavage
rates were evaluated (Table 2). Micronucleus- injected
(+), Parthenogenetic (+) and Parthenogenetic (−) groups
showed higher cleavage rates than the Micronucleus-
injected (−) treatment [93/108 (86.11%), 111/136
(81.62%) and 160/186 (86.02%) respectively vs. 80/108
(74.07%)] (p≤0.05). Cleavage rates of the Enucleated (+)
group [78/105 (74.3%)] did not differ from Micronu-
cleus- injected (−), and Parthenogenetic (+) treatments
(p≤0.05). Cleavage rates were similar between groups
(Table 2), except for the Micronucleus- injected (−)
group, which showed a lower rate (81.62 to 86.11 vs.
64.91%) (p≤0.05). It is important to notice that rates of
cleavage are difficult to discern from those of fragmenta-
tion for the Micronucleus- injected and Enucleated groups.
We considered as cleaved all embryos with more than 2
blastomeres, independent of their symmetry. This was
based on the fact that embryos reconstituted with micro-
nuclei showed both symmetric and asymmetric cells.
In experiment 2, egfp expression was also analyzed.
Interestingly, a low number of Micronucleus- injected
(+) embryos showed egfp expression. Expression levels
were significantly lower than those observed for the Par-
thenogenetic (+) control (2.15 vs. 38.74% respectively)
and they did not differ from the Enucleated (+) control,
which did not show egfp expression at all (p≤0.05). From
these data, we can conclude that it is not necessary for
the oocyte to have an entire nucleus to allow the trans-
gene to be expressed. According to our hypothesis, the
membranes surrounding micronuclei could have bounditors and mitomycin for the induction of







.1 μg/ml DMC (Demecolcine); or 0.05 μg/ml Col (Colchicine) for 46 or 48 h. In
(Mitomycin) for 2 h.
).
Table 2 Cleavage and egfp expression rates of Micronucleus- injected bovine oocytes
Treatment pCX-EGFP N Cleavage (%) egfp expressing embryos (%)
Micronucleus- injected - 108 80 (74.07)a -
+ 108 93 (86.11)bc 2 (2.15)a
Parthenogenetic - 186 160 (86.02)bc -
+ 136 111 (81.62)ac 43 (38.74)b
Enucleated + 105 78 (74.29)a 0a
Micronucleus- injected (−) (embryos generated from enucleated oocytes injected with one micronucleus and parthenogenetically activated), Micronucleus-
injected (+) (embryos generated from enucleated oocytes injected with one micronucleus previously incubated with pCX-EGFP and parthenogenetically activated),
Parthenogenetic (−) (parthenogenetically activated oocytes), Parthenogenetic (+) (parthenogenetically activated oocytes injected with pCX-EGFP), Enucleated (+)
(enucleated oocytes injected with pCX-EGFP and parthenogenetically activated). egfp expressing embryos: embryos with 2 or more egfp expressing blastomeres
(expressing embryos/cleaved embryos).
a,b,c: Values with different superscripts in the same column significantly differ (p≤0.05).
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in the media during the injection of the micronuclei, as
this is the way in which we produced the egfp expressing
parthenogenetic control embryos. The transgene was
delivered directly into the cytoplasm of the parthenotes
by microinjection, before chemical activation. In a previ-
ous work done in our laboratory, eDNA alone was
injected into MII oocytes in the same way and concen-
tration of pCX-EGFP than in the present study, giving
rise to a 25% of egfp expressing embryos at day 4 of
in vitro development [50]. In a second study from our
group, Bevacqua et al. [55] reported 50% of egfp expres-
sing embryos, working under the same conditions.
Although egfp expression was observed in Micronucleus-
injected group, rates of expression were low. This result
could indicate that a non complete nucleus is not as effi-
cient as an entire nucleus to support transgene expression.
One possible explanation for the latter observation could
be the unusual structure that the micronucleus adopts at
the interphase stage. There are several indirect evi-
dences that suggest that the inner nuclear membrane
might have a repressor action over transcription of
many genes. One of these is that heterochromatin is
usually positioned near the periphery of the nucleus
[56]. In our work, we used micronuclei as nuclear
donors which must have a different content of chro-
mosomes; their transcription (and also those of the
transgene) could have been repressed or not, depend-
ing on the position of the chromosomes within the
nuclear envelope. On the other hand, egfp expression
observed in the Enucleated (+) group was zero, while
a 38.74% rate of expression shown by the Partheno-
genetic (+) control group is evidence that the pres-
ence of a nucleus is necessary for transgene
expression. These results agree with Spann TP et al.
[57] who reported an association between the normal
structure of Xenopus embryo nucleus and the occur-
rence of transcription.
To confirm replication of DNA, some Micronucleus-
injected (−) and Parthenogenetic (−) cleaved embryos
were fixed and stained with DAPI (Figure 1). Thepresence of more than one micronucleus per embryo
was evaluated. Although rates of Micronucleus- injected
(−) embryos with more than 1 nucleus (63.6%, n=22)
were lower than those for the Parthenogenetic (−) group
(100%, n=28) (p≤0.05), DAPI staining confirmed replica-
tion of micronuclei. From these data, we concluded that
early cleavage is not dependant on the presence of a
complete nucleus. These observations could be explained
by the timing of zygote genome activation. In bovine
embryos, low transcription activity is observed before the
4-cell stage [58-60]. However, protein synthesis is supposed
to be programmed by maternal mRNA up to the 8-cell. It
is between the 8-cell and 16-cell stage when the zygote
genome becomes activated, and the higher transcription
levels are detected [61,62]. Thus, in this context, the cyto-
plast could cleave without the presence of an entire
nucleus. To our knowledge, this is the first report of the
production of reconstituted embryos using micronuclei as
nuclear donors.
Chromosomal analysis of micronucleus injected embryos
Karyotypes of Micronucleus- injected (−) embryos were
studied (Table 3 and Figure 2). Parthenogenetic (−) and
IVF controls were also included. All Micronucleus-
injected (−) embryos analyzed had fewer than 15 chro-
mosomes, while none of the controls showed such results.
Eighteen blastomeres from 11 Micronucleus- injected (−)
embryos were counted. All evaluated embryos had at least
two nuclei, at metaphase or interphase. Numbers of chro-
mosomes per blastomere varied from 1 to 13, with a me-
dian of 7. The number of chromosomes in blastomeres
from each of the eleven analyzed embryos were: 8, 8, 7, 11
and 11; 7 and 8; 10 + interphase in 4 embryos; 13 + inter-
phase; 6 + interphase; 1 + interphase; 2 and 2; 3 and 1.
Despite the efficiency of individual chromosome embryo
production should be improved, these results indicate that
the oocyte is capable of replicating a low number of
chromosomes. It is important to note that the number of
chromosomes injected into the enucleated oocytes
might have been different from those we were able to
count after cell divisions, as a result of chemical
Figure 1 Assessment of nuclear replication. (a) Micronucleus- injected and (b) Parthenogenetic cleaved embryo observed under UV light after
DAPI staining. (a’ and b’): The same embryos under bright light. Arrows indicate DNA staining (200X).
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thenogenetic [34,35,63] and SCNT bovine embryos
[64,65] show a high incidence of abnormal karyotypes,
after DMAP activation. Some authors have attributed
these anomalies to the accelerated pronuclear forma-
tion and premature DNA synthesis observed in
DMAP-activated oocytes, followed by karyokinesis
without cytokinesis during the first cell cycle [35].
Such observations correlate with our results, which
showed 55% of anomalies, while IVF controls only
showed 15%. In the future, this new technique could
be modified to allow the replication of blastomeres
containing a unique chromosome, leading to a simple
way of individual chromosome transfer which could
have a wide range of applications.Table 3 Ploidy of micronucleus injected bovine embryos
Treatment N Spreads
Less th
Micronucleus- injected 11 18
Parthenogenetic 20 52
IVF 20 49
Micronucleus- injected (embryos generated from enucleated oocytes injected with
(parthenogenetically activated oocytes), IVF (embryos generated by in vitro fertilizat
tetraploid + mixoploid + aneuploid.
a,b:Values with different superscripts in the same column significantly differ (p≤0.05Conclusions
In this study we have demonstrated that bovine ooplasts
are capable of replicating micronuclei with a low num-
ber of chromosomes. The number of replicated chromo-
somes in each micronucleus was confirmed to be
between 1 and 13. Moreover, it was observed that some
of the transferred micronuclei expressed a foreign DNA,
which means that it is not necessary for the oocyte to
have an entire nucleus to allow the expression of a
transgene. For the first time, MMCT was used to pro-
duce SCNT embryos, using micronuclei as nuclear
donors. In conclusion, we have developed a new method
to clone a small number of chromosomes, which could
be a useful tool to transfer individual chromosomes and
to target transgenesis to a specific area of the genome.Embryos
an 15 chromosomes (%) Euploid (%) Others (%)
11 (100)a 0a 0a
0b 9 (45)b 11 (55)b
0b 15 (75)b 3 (15)a
one micronucleus and parthenogenetically activated), Parthenogenetic
ion). %: percentages over total embryos. Euploid: haploid + diploid. Others:
).
Figure 2 Chromosomal analysis. Spreads from (a) Micronucleus- injected (less than 1n), (b) IVF (2n) and (c) Parthenogenetic cleaved embryo
(4n) treated with colchicine and stained with Giemsa (1000X).
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a strategy for sex chromosomes interchange. It would
make it possible to exchange an X chromosome for a Y
chromosome, which could have been previously modi-
fied to carry a transgene of interest. In this way, the
resulting male would be able to produce millions of
gametes instead of hundreds and would have the trans-
gene integrated into the Y chromosome, which has a few
genes and therefore reduced position effects.
Methods
Unless otherwise indicated, all chemicals were purchased
from Sigma Chemical Company (St. Louis, MO, USA).
Cumulus–oocyte complexes (COCs) collection and in vitro
maturation (IVM)
Cow ovaries were transported from a local slaughter-
house to the laboratory in a thermo container at 24 to
27°C. Cumulus oocyte complexes (COCs) were aspirated
from follicles with a diameter of 2–8 mm into Dulbecco’s
phosphate-buffered saline (DPBS; 14287–072; Gibco BRL,
Grand Island, NY, USA) containing 10% v/v fetal bovine
serum (FBS; 10499–044; Gibco BRL) and 1% v/v anti-
biotic–antimycotic (ATB; 15240–096; Gibco BRL).
Oocytes covered with at least three layers of granulosa
cells were selected for IVM. The maturation medium was
bicarbonate-buffered TCM-199 (31100–035; Gibco BRL),
containing 2 mM glutamine (G-8540), 10% v/v FBS,
2 mg/ml follicle-stimulating hormone (NIH-FSH-P1; Foll-
tropin; Bioniche, Belleville, Ontario, Canada), 0.3 mM so-
dium pyruvate (P2256), 100 mM cysteamine (M9768), and
1% v/v ATB. Groups of 25 COCs were in vitro matured in
100 μL droplets of maturation medium covered with min-
eral oil (M8410), at 39°C in a humidified atmosphere of6% CO2 in air. After 21–24 h of IVM, cumulus cells
were removed from COCs by vortexing for 3 min in
1 mg/ml hyaluronidase solution (H-4272) and washed
three times in HEPES-TALP. Oocytes with an extruded
first polar body (PB) were selected for enucleation and
intracytoplasmic micronucleus injection or chemical
activation.
Preparation of donor cells
Somatic cell cultures were established from slaughtered
cow ovaries. Ovarian explants were cultured in 35x100
mm culture dishes (353001; Falcon, USA) with Dulbecco
modified Eagle medium (DMEM; 11885 Low glucose;
Invitrogen, Grand Island, NY, USA) supplemented with
10% v/v FBS and 3% v/v ATB, at 39°C in a humidified at-
mosphere of 6% CO2 in air. After about 2 weeks, fibro-
blast monolayers reached confluence and were removed
and placed into new culture dishes. For passages, cells
were washed with DPBS and digested with 0.05%
trypsin-EDTA (25300; Gibco, Grand Island, NY) for 5
min at 37°C. The reaction was terminated by adding
supplemented DMEM and the collected cells were
resuspended and divided into new dishes.
Induction of somatic micronucleate cells
Ovarian bovine fibroblasts at approximately 80% conflu-
ence with less than 5 passages were blocked in meta-
phase by incubation with 0.05 or 0.1 μg/ml demecolcine
(DMC; D1925); or 0.05 μg/ml colchicine (Col; C3915) in
DMEM for 46 or 48 h. In order to complete mitotic
arrest, some cells were then incubated with 2 mg/ml
mitomycin (Mit; M-4287) for 2 h. The cells were subse-
quently washed with DPBS and, in all cases, were incubated
in DMEM medium supplemented with 10 to 15 μg/ml
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assayed were: DMC 0.05 μg/ml; DMC 0.05 μg/ml + Mit;
DMC 0.1 μg/ml; DMC 0.1 μg/ml + Mit; Col 0.05 μg/ml;
and Col 0.05 μg/ml + Mit. All treated cells were trypsi-
nized and immediately centrifuged at 1200 r.p.m for 5
min, at 37°C. The pellet was resuspended in 200 μl of
FBS-free DMEM medium and the resulting suspension
containing micronucleate cells was transferred to 100 μl
droplets of TALP-Hepes with 1 mg/ml of Hoechst Bisben-
zimide 33342 (H33342, B-2261). After 10 min, cells were
observed under a fluorescence microscope to analyze the
percentage of micronucleate cells and the number of
micronuclei per cell. For injection procedures, cells were
exposed to DMC 0.05 μg/ml + Mit + CB 10 μg/ml treat-
ment, then trypsinized and immediately used as nuclear
donors as described below.
DNA construction
The plasmid used was pCX-EGFP kindly provided by
Dr. Masaru Okabe (Osaka University, Osaka, Japan) that
contains the enhanced green fluorescent protein gene
(egfp) under the chimeric cytomegalovirus-IE-chicken
β-actin enhancer-promoter control [66]. The plasmid
was linearized by Hind III digestion.
Enucleation and intracytoplasmic micronucleus injection
After 21 h of IVM, MII oocytes were denuded and
stained with 1 mg/ml of H 33342 for 10 min. Immedi-
ately, oocytes were transferred into 100 μl droplets of
Hepes-TALP supplemented with 0.3 g/ml BSA, under
mineral oil, in 100x20 mm tissue culture dishes (430167;
Corning, NY, USA) and mechanically enucleated using a
Narishige hydraulic micromanipulator (Narishige Sci.,
Tokyo, Japan) mounted on a Nikon Eclipse E-300 micro-
scope (Nikon, Melville, NY, USA). Enucleation was
performed using a 20 μm internal diameter pipette.
Metaphase chromosomes were visualized under ultravio-
let light (<10 sec) and aspirated into the pipette with a
minimal volume of ooplasm. Chromosome removal was
confirmed by the presence of stained MII chromosomes
inside the pipette. Donor somatic cells were transferred to
TALP-Hepes droplets supplemented with 10 μg/ml CB
and 1 mg/ml of H 33342. After 10 min, micronucleate
cells were identified and transferred to 3 μl droplets of
10% v/v polyvinylpyrrolidone solution (PVP; 99219; Irvine
Sci., Irvine, CA, USA) in HEPES-TALP, with or without
50 ng/μl pCX-EGFP for injection. After an incubation of
at least 5 min, the cell membrane was broken by gentle
aspiration in and out of the injection pipette (inner diam-
eter of 7 μm) and a single micronucleus was injected into
the cytoplasm of each enucleated oocyte (Micronucleus-
injected groups). Aspiration was used to break the
oolemma. The somatic micronucleus and the aspirated
ooplasm were then expelled into the oocyte with aminimal volume of PVP (<10 pl). Enucleated and some
parthenogenetic controls were injected with 50 ng/μl
pCX-EGFP in 10% v/v PVP into the ooplasm, using a vol-
ume that was equivalent to that used for to the injection of
micronuclei (<10 pl). A parthenogenetic control (non
injected) was also included. After injection, all groups were
subjected to chemical activation as described below.
Chemical activation
Metaphase II oocytes and Micronucleus- injected embryos
were treated with 5 μM ionomycin (I24222; Invitrogen,
Carlsbad, CA, USA) in HEPES-TALP for 4 min, followed
by incubation for 3 h in 1.9 mM 6-DMAP, (D2629) diluted
in TCM-199 medium. Afterwards, oocytes were thor-
oughly washed in HEPES-TALP and cultured as described
below. Prior to activation, Micronucleus- injected embryos
were held for 2 h in 100 μl droplets of TCM-199 to allow
the reprogramming events.
IVF procedure
The IVF procedure was previously described by Brackett
and Oliphant [67]. Briefly, frozen semen was thawed in a
37°C water bath for 30 sec. The sperm were washed
twice by centrifugation at 490g x 5 min with Brackett’s
defined medium. Sperm concentration was adjusted to
20x106/ml and sperm were then coincubated for 5 h
with COCs in Brackett’s fertilization medium. Afterward,
presumptive zygotes were washed several times in
HEPES-TALP and in vitro cultured as described below.
In vitro culture
Embryos were in vitro cultured in 50 μl droplets of syn-
thetic oviductal fluid (SOF) [68] modified by Holm et al.
[69] containing 2.5% v/v FBS under mineral oil, at 39°C
in a humidified atmosphere of 6% CO2 in air. Cleavage
stage was evaluated at day 2 of in vitro development.
Evaluation of pCX-EGFP expression in embryos
Embryos injected with pCX-EGFP were briefly exposed
to blue light using an excitation- filter at 488 nm and an
emission-filter at 530 nm to determine egfp expression
at day 4 of in vitro development.
Assessment of nuclear replication
Forty-eight hours after activation, Micronucleus- injected
and Parthenogenetic embryos were transferred to Hepes-
TALP droplets and treated with 1.5 mg/ml pronase for 3
min to remove all zonae pellucidae. Afterward, embryos
were fixed with methanol: acetic acid solution (3:1, v: v)
and DNA was stained with DAPI (D9542). Nuclei were
visualized and counted using UV light under a fluores-
cence microscope. Embryos with more than one nucleus
were considered to have replicated their DNA.
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Forty-eight hours after activation, Micronucleus- injected,
Parthenogenetic, and IVF embryos were cultured for 6 h
in SOF medium containing 1.25 μg/ml colchicine (C3915)
and transferred to a trisodium citrate hypotonic solution
(F71497; 0.9 % w/v in distilled water) for 13 min at 37°C.
Subsequently, embryos were placed on a clean glass slide
in a small volume of medium and a methanol: acetic acid
solution (3:1, v: v) was applied. After air drying, fixed
embryos were stained with 5% v/v Giemsa solution
(1.09204.1002; Merck, Darmstadt, Germany) in distilled
water for 10 min. Chromosome spreads were examined
under a 100X oil magnification objective and chromo-
somal complements were determined for each embryo
which was classified as: less than 15 chromosomes, eu-
ploid (1n and 2n), and others, which included tetraploid
(4n), mixoploid (embryos with blastomeres of different
ploidies), and aneuploid. Only those spreads which were
clearly in metaphase were analyzed.Statistical analysis
Each experiment was repeated at least three times. Dif-
ferences between treatments in each experiment were
determined by Fisher’s exact test using Graph Pad
PRISMW software 5.01 version. Differences between
media of micronuclei per cell were analyzed for signifi-
cance using the one way ANOVA. For all analyses a dif-
ference of p≤0.05 was considered to be significant.Figure 3 Methodological design. Micronuclei formation was
induced by incubation in 0.05 μg/ml demecolcine for 46 h followed
by 2 mg/ml mitomycin for 2 h. Cells were then treated with 10 μg/
ml cytochalasin B for 1 h. MII oocytes were mechanically enucleated
and injected with one somatic micronucleus, which were previously
exposed or not to pCX-EGFP. After 2 h, oocytes and reconstituted
embryos were chemically activated. After 48 h of IVC, cleavage stage
was assessed. Moreover, the DNA from some embryos was stained
with DAPI for evaluation of nuclear replication and others were
karyotyped. At day 4 of IVC, egfp expression was evaluated.Experimental design
In experiment 1, six different treatments were assayed
on primary fibroblast cultures to induce micronucleus
formation. In experiment 2, the best treatment from
experiment 1 was employed to generate micronuclei,
which were used as nuclear donors of reconstituted
embryos. The methodology is shown in Figure 3. Briefly,
micronucleus formation was induced by incubation in
0.05 μg/ml demecolcine for 46 h followed by 2 mg/ml
mitomycin for 2 h. Cells were then treated with 10 μg/ml
cytochalasin B for 1 h. Metaphase II oocytes were me-
chanically enucleated and injected with one somatic
micronucleus, which had been previously exposed or not
to pCX-EGFP. Enucleated oocytes and parthenogenetic
controls were injected with 50 ng/μl pCX-EGFP. A non
injected parthenogenetic control was also included. After 2
h, oocytes and reconstituted embryos were chemically acti-
vated. Cleavage stage and egfp expression were evaluated.
Additionally, DNA replication from some Micronucleus-
injected and Parthenogenetic embryos was confirmed by
DAPI staining. In experiment 3, Micronucleus- injected,
Parthenogenetic and in vitro fertilized (IVF) embryos were
karyotyped. Methodological design is summarized in
Figure 3.
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